Cancer
Open Access until Oct. 24th: Special Issue on Integrative Oncology from JACM
A recent special focus issue on integrative oncology deserves a solid read. In light of the recent controversial article in JAMA on complementary and alternative cancer therapies, this special issue by JACM, The Journal of Alternative and Complementary Medicine, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers, puts a lensRead
Gut Microbiota Feeds Colon Cancer Cells
Retraction Needed? JAMA Oncology’s Bum Science Suggests People Die Faster Using Complementary Medicine
The media had a feeding frenzy when a data-mining report from Yale researchers published in JAMA Oncology suggested a causal relationship between use of complementary medicine and shortened life span among cancer patients. A New York Times subheading was representative: “People who used herbs, acupuncture and other complementary treatments tended to die earlier than those whoRead
Early Lab Study: Hemp Shows Therapeutic Potential for Reducing Ovarian Cancer Risk
Could non-psychoactive hemp be a viable use to reduce ovarian cancer risk? As we learn more about the bioactives in hemp, the possibility becomes ever real. At the 2018 annual Experimental Biology meeting in San Diego, graduate students, Sara Biela and Chase Turner, presented the first study to examine hemp andRead
Is Aspirin Beneficial? That Depends on Dosage and Body Weight, says Lancet study
It is well known that aspirin can inhibit the aggregation of platelets and reduce the risk of certain cancers such as colorectal cancer, thus the commonly prescribed recommendation of 81mg baby aspirin (one quarter the dose of 325 mg adult aspirin). This Lancet study explored the one-dose-fits all approachRead
Dr. Nalini Chilkov: Integrative Oncology & The Important Role of Frontline Clinicians
In this insightful video from Functional Forum, Nalini Chilkov, OMD, leading integrative oncology expert and founder of the American Institute of Integrative Oncology Research and Education, discusses the importance of focusing on a patient’s overall health while treating cancer. As health specialists in integrative care, you can do more than youRead
Lesson from Oncology Clinic on Improving Nonclinical-Support for Patients
Breast Cancer Joins Pain as Conditions with Dominant School Endorsement of Integrative Strategies
The movement of medicine toward an integrative model took an important step in early June. The American Society of Clinical Oncology (ASCO) endorsed a clinical practice guideline for integrative therapies during and after breast cancer treatment. The endorsement was published on June 11, 2018 in ASCO’s Journal of Clinical Oncology as “Integrative TherapiesRead
Vitamin D and Colorectal Cancer Study: More Evidence it is Time to Rethink the IOM Recommendations
Could the third leading cause of cancer be prevented with Vitamin D? A new study authored by scientists from the American Cancer Society, the Harvard T.H. Chan School of Public Health, the U.S. National Cancer Institute, and more than 20 other medical centers and organizations finds that higher circulating vitaminRead
Dr Geo Espinosa on the Recent Change in Prostate Cancer Screening Guidelines
On May 8, 2018, the United States Preventive Services Task Force (USPSTF) issued new recommendations for prostate screening, published in Journal of the American Medical Association (JAMA), for prostate screening, stating “Clinicians should not conduct prostate cancer screening in men aged 55-69 years who do not ask for it (level C recommendation).”Read
